Sequence information
Variant position: 2553 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 2754 The length of the canonical sequence.
Location on the sequence:
HQGGLSVGLAPKPVQVLYGH
G AAVSCVAISTELDMAVSGSE
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human HQGGLSVGLAPKPVQVLYGHG AAVSCVAISTELDMAVSGSE
Mouse QQSGLSAGLAPKPVQVLYGHV AAVSCVAISTELDMAVSGSE
Zebrafish QQGGFSSGLSPRPIQVLCGHD QEVTCVAISTELDMAISGSK
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Literature citations
Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome.
Albers C.A.; Cvejic A.; Favier R.; Bouwmans E.E.; Alessi M.C.; Bertone P.; Jordan G.; Kettleborough R.N.; Kiddle G.; Kostadima M.; Read R.J.; Sipos B.; Sivapalaratnam S.; Smethurst P.A.; Stephens J.; Voss K.; Nurden A.; Rendon A.; Nurden P.; Ouwehand W.H.;
Nat. Genet. 43:735-737(2011)
Cited for: FUNCTION; TISSUE SPECIFICITY; VARIANTS GPS PRO-388; VAL-643; LEU-2100 AND LEU-2269; VARIANTS VAL-86; PHE-682 AND GLU-2553;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.